 |
23 Diseases |  |
12 Trials |
|
12 Trials |  |
1306 News |  |
| «12...3456789101112131415» |
- Trial completion date: IMPACT: Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics (clinicaltrials.gov) - May 14, 2014
P4, N=127, Completed, Sponsor: Johns Hopkins University
Trial completion date: Apr 2014 --> Mar 2014
- Trial completion: IMPACT: Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics (clinicaltrials.gov) - May 14, 2014
P4, N=127, Completed, Sponsor: Johns Hopkins University
Trial completion date: Apr 2014 --> Mar 2014 Recruiting --> Completed
- ||| risperidone / Generic mfg., lurasidone / Generic mfg.
Enrollment open: A Clinical Trial of Lurasidone in Treatment of Schizophrenia (clinicaltrials.gov) - May 13, 2014
P=N/A, N=380, Recruiting, Sponsor: Sumitomo Pharmaceutical (Suzhou) Co., Ltd.
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| lurasidone / Generic mfg.
Enrollment closed: Lurasidone Low-Dose - High-Dose Study Study (clinicaltrials.gov) - Apr 20, 2014
P3, N=400, Active, not recruiting, Sponsor: Sunovion
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- |||| haloperidol / Generic mfg., lurasidone / Generic mfg.
Trial completion: A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia (clinicaltrials.gov) - Apr 15, 2014
P2, N=356, Completed, Sponsor: Sunovion
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||| lurasidone / Generic mfg.
Trial completion: Safety and Tolerability Study of Drug to Treat Schizophrenia (clinicaltrials.gov) - Apr 15, 2014
P2, N=98, Completed, Sponsor: Sunovion
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||| lurasidone / Generic mfg.
Enrollment open: Illuminate: Lurasidone Pediatric Bipolar Study (clinicaltrials.gov) - Apr 2, 2014
P3, N=340, Recruiting, Sponsor: Sunovion
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| lurasidone / Generic mfg.
Enrollment change: A Twelve Week, Open Label Extension Study in Patients With Schizophrenia (clinicaltrials.gov) - Apr 1, 2014
P3, N=191, Completed, Sponsor: Sunovion
Not yet recruiting --> Recruiting N=250 --> 191
- ||||||| lurasidone / Generic mfg.
Trial completion: A Twelve Week, Open Label Extension Study in Patients With Schizophrenia (clinicaltrials.gov) - Apr 1, 2014
P3, N=191, Completed, Sponsor: Sunovion
N=250 --> 191 Active, not recruiting --> Completed
- ||||| lurasidone / Generic mfg.
Enrollment change: Lurasidone Extended Use Study (clinicaltrials.gov) - Mar 18, 2014
P3, N=162, Completed, Sponsor: Sunovion
Active, not recruiting --> Completed N=600 --> 162
- ||||||| lurasidone / Generic mfg.
Trial completion: Lurasidone Extended Use Study (clinicaltrials.gov) - Mar 18, 2014
P3, N=162, Completed, Sponsor: Sunovion
N=600 --> 162 Recruiting --> Completed
- lurasidone / Generic mfg.
Enrollment closed: Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents (clinicaltrials.gov) - Feb 6, 2014
P2, N=30, Active, not recruiting, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Completed Recruiting --> Active, not recruiting
- lurasidone / Generic mfg.
Trial initiation date: Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old (clinicaltrials.gov) - Jan 26, 2014
P4, N=40, Not yet recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Active, not recruiting Initiation date: Oct 2013 --> Feb 2014
- |||||||||| lurasidone / Generic mfg.
New P3 trial: Illuminate: Lurasidone Pediatric Bipolar Study (clinicaltrials.gov) - Jan 23, 2014
P3, N=340, Recruiting, Sponsor: Sunovion
- |||||| lurasidone / Generic mfg.
Enrollment open: Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia (clinicaltrials.gov) - Nov 20, 2013
P3, N=435, Recruiting, Sponsor: Dainippon Sumitomo Pharma
Initiation date: Oct 2013 --> Feb 2014 Not yet recruiting --> Recruiting
- |||||| lurasidone / Generic mfg.
Enrollment open: A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia (clinicaltrials.gov) - Nov 20, 2013
P3, N=435, Recruiting, Sponsor: Dainippon Sumitomo Pharma
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||||||||| lurasidone / Generic mfg.
New P3 trial: A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder. (clinicaltrials.gov) - Nov 14, 2013
P3, N=405, Not yet recruiting, Sponsor: Dainippon Sumitomo Pharma
- |||||||||| lurasidone / Generic mfg.
New P3 trial: A Phase III Study of SM-13496 in Patients With Bipolar I Depression. (clinicaltrials.gov) - Nov 14, 2013
P3, N=501, Not yet recruiting, Sponsor: Dainippon Sumitomo Pharma
- ||| lurasidone / Generic mfg.
New P3 trial: A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone (clinicaltrials.gov) - Nov 6, 2013
P3, N=28, Completed, Sponsor: University of California, Irvine
- | lurasidone / Generic mfg.
Enrollment change: RESOLVE3: Major Depressive Disorder With Mixed Features - Extension (clinicaltrials.gov) - Nov 3, 2013
P3, N=48, Completed, Sponsor: Sunovion
Not yet recruiting --> Recruiting N=300 --> 48
- || lurasidone / Generic mfg.
Trial completion: RESOLVE3: Major Depressive Disorder With Mixed Features - Extension (clinicaltrials.gov) - Nov 3, 2013
P3, N=48, Completed, Sponsor: Sunovion
N=300 --> 48 Active, not recruiting --> Completed
- |||||| lurasidone / Generic mfg.
Enrollment open: Lurasidone Pediatric Autism Study (clinicaltrials.gov) - Sep 3, 2013
P3, N=150, Recruiting, Sponsor: Sunovion
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- lurasidone / Generic mfg.
New P4 trial: Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old (clinicaltrials.gov) - Aug 28, 2013
P4, N=40, Not yet recruiting, Sponsor: Massachusetts General Hospital
- ||||||| lurasidone / Generic mfg.
Trial completion: PEARL Schizophrenia Maintenance (clinicaltrials.gov) - Aug 8, 2013
P3, N=285, Completed, Sponsor: Sunovion
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- |||||||||| lurasidone / Generic mfg.
New P3 trial: Pediatric Open-Label Extension Study (clinicaltrials.gov) - Jul 31, 2013
P3, N=295, Recruiting, Sponsor: Sunovion
- |||||||||| lurasidone / Generic mfg.
New P3 trial: Lurasidone Pediatric Autism Study (clinicaltrials.gov) - Jul 28, 2013
P3, N=150, Recruiting, Sponsor: Sunovion
- |||||||||| lurasidone / Generic mfg.
New P3 trial: Pediatric Schizophrenia Efficacy and Safety Study (clinicaltrials.gov) - Jul 28, 2013
P3, N=249, Recruiting, Sponsor: Sunovion
- |||||| lurasidone / Generic mfg.
Enrollment open: RESOLVE 1: Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose (clinicaltrials.gov) - Jul 17, 2013
P3, N=200, Recruiting, Sponsor: Sunovion
Active, not recruiting --> Completed Active, not recruiting --> Recruiting
- || asenapine / Generic mfg.
Enrollment closed: An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) (clinicaltrials.gov) - May 14, 2013
P=N/A, N=3000, Active, not recruiting, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Recruiting Not yet recruiting --> Active, not recruiting
- ||| lurasidone / Generic mfg.
Trial completion: Lurasidone Pediatric Pharmacokinetics Study (clinicaltrials.gov) - May 12, 2013
P1, N=105, Completed, Sponsor: Sunovion
Not yet recruiting --> Active, not recruiting Recruiting --> Completed
- |||||||||| lurasidone / Generic mfg.
New P3 trial: Lurasidone Low-Dose - High-Dose Study Study (clinicaltrials.gov) - Mar 28, 2013
P3, N=400, Active, not recruiting, Sponsor: Sunovion
- ||||| lurasidone / Generic mfg.
Enrollment change: Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression (clinicaltrials.gov) - Feb 21, 2013
P3, N=819, Completed, Sponsor: Sunovion
Recruiting --> Completed N=500 --> 819
- ||||||| lurasidone / Generic mfg.
Trial completion: Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression (clinicaltrials.gov) - Feb 21, 2013
P3, N=819, Completed, Sponsor: Sunovion
N=500 --> 819 Active, not recruiting --> Completed
- lurasidone / Generic mfg.
Trial withdrawal: RESOLVE2: Major Depressive Disorder With Mixed Features (clinicaltrials.gov) - Dec 10, 2012
P3, N=0, Withdrawn, Sponsor: Sunovion
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- lurasidone / Generic mfg.
Enrollment change: RESOLVE2: Major Depressive Disorder With Mixed Features (clinicaltrials.gov) - Dec 10, 2012
P3, N=0, Withdrawn, Sponsor: Sunovion
Not yet recruiting --> Withdrawn N=360 --> 0
- lurasidone / Generic mfg.
New P2 trial: Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents (clinicaltrials.gov) - Nov 19, 2012
P2, N=30, Active, not recruiting, Sponsor: University of North Carolina, Chapel Hill
- ||||||| lithium carbonate ER / Generic mfg., lurasidone / Generic mfg.
Trial completion: PREVAIL3: Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression (clinicaltrials.gov) - Aug 12, 2012
P3, N=356, Completed, Sponsor: Sunovion
N=360 --> 0 Active, not recruiting --> Completed
- ||| lurasidone / Generic mfg.
New P1 trial: Lurasidone Pediatric Pharmacokinetics Study (clinicaltrials.gov) - Jun 13, 2012
P1, N=105, Completed, Sponsor: Sunovion
- ||||||| lurasidone / Generic mfg.
Trial completion: Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia (clinicaltrials.gov) - Jun 10, 2012
P3, N=440, Completed, Sponsor: Dainippon Sumitomo Pharma
Active, not recruiting --> Completed Recruiting --> Completed
- |||||||||| lurasidone / Generic mfg.
New P3 trial: Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia (clinicaltrials.gov) - Jun 6, 2012
P3, N=435, Recruiting, Sponsor: Dainippon Sumitomo Pharma
- |||||||||| lurasidone / Generic mfg.
New P3 trial: A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia (clinicaltrials.gov) - Jun 6, 2012
P3, N=435, Recruiting, Sponsor: Dainippon Sumitomo Pharma
- | lurasidone / Generic mfg.
Biomarker, Enrollment open: Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone (clinicaltrials.gov) - May 21, 2012
P3, N=140, Recruiting, Sponsor: University of California, Los Angeles
Recruiting --> Completed Active, not recruiting --> Recruiting
- Enrollment change: IMPACT: Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics (clinicaltrials.gov) - Apr 19, 2012
P4, N=132, Recruiting, Sponsor: Johns Hopkins University
Active, not recruiting --> Recruiting N=240 --> 132
- |||||||||| lurasidone / Generic mfg.
New P3 trial: PERSISTExt: This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 (clinicaltrials.gov) - Apr 9, 2012
P3, N=500, Recruiting, Sponsor: Sunovion
- ||||| lurasidone / Generic mfg.
New P4 trial: High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia (clinicaltrials.gov) - Apr 1, 2012
P4, N=120, Recruiting, Sponsor: Northwestern University
- |||||||||| lurasidone / Generic mfg.
New P3 trial: A Twelve Week, Open Label Extension Study in Patients With Schizophrenia (clinicaltrials.gov) - Mar 27, 2012
P3, N=191, Completed, Sponsor: Sunovion
- ||||||| lurasidone / Generic mfg.
Trial completion, Monotherapy: Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) (clinicaltrials.gov) - Feb 15, 2012
P3, N=505, Completed, Sponsor: Sunovion
N=240 --> 132 Active, not recruiting --> Completed
- ||||||| lithium carbonate ER / Generic mfg., lurasidone / Generic mfg.
Trial completion: Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on) (clinicaltrials.gov) - Jan 19, 2012
P3, N=348, Completed, Sponsor: Sunovion
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| lurasidone / Generic mfg.
Trial completion: Switch Ext: A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder (clinicaltrials.gov) - Jan 16, 2012
P3, N=149, Completed, Sponsor: Sunovion
Active, not recruiting --> Completed Active, not recruiting --> Completed
- PK/PD data: PTN_POPS: Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care (clinicaltrials.gov) - Jan 3, 2012
P=N/A, N=500, Recruiting, Sponsor: Daniel Benjamin
Active, not recruiting --> Completed Not yet recruiting --> Recruiting